Photo: Karen Ducey / Getty Images
Vaccine advisers at the Centers for Disease Control and Prevention (CDC) voted Thursday to recommend booster doses of the Covid-19 vaccines by Moderna and Johnson & Johnson.
CDC’s Advisory Committee on Immunization Practices accepted Food and Drug Administration (FDA) emergency use authorizations for each of these booster doses Covid-19 vaccines, after considerable discussion as to whether such a broad authorization was needed for the Covid-19 vaccine by Moderna.
Members agreed that the people who received the Covid-19 vaccine Johnson & Johnson need a second vaccine, as that vaccine is less effective than Moderna and Pfizer’s in preventing infections, according to CNN.
Now it will depend on the director of the CDC, the Dr. Rochelle Walensky, accept or modify the committee’s recommendation. The CDC director generally follows the guidance of the advisory committee.
The CDC will also issue a clinical guide detailing what people should consider when seeking and receiving Covid-19 vaccines reinforcement. This guide will also include whether people should mix and match. Covid-19 vaccines reinforcement.
The FDA granted emergency use authorization Wednesday for booster doses of Moderna and Johnson & Johnson’s Janssen vaccines.
The FDA also authorized a combination approach of initial doses and boosters of Covid-19 vaccines, saying that eligible individuals could receive any vaccine as a booster, regardless of the vaccine they received for the initial immunization.
Nearly 190 million people in the United States are fully vaccinated against the coronavirus. In general, Covid-19 vaccines have been shown to be safe.
Still, some rare side effects have been identified, raising concern among some of the committee members that an extra dose would further increase the risk for some people.
It may interest you: